News ( Year: 2021 )

9 November, 2021

Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next-Generation Precision Editing Therapeutics

The most extensive toolbox of proprietary genomic editors in the industry to enable development of curative, next-generation genetic medicines Co-founded by David Walt, Ph.D. and Feng Zhang, Ph.D. CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) — Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the completion of […]

Read More
2 November, 2021

Shoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell Immunotherapies

Financing accelerates the growth of Shoreline’s pipeline of iPSC-based cell immunotherapies for the treatment of seriously ill patients and enables the buildout of smart manufacturing capabilities SAN DIEGO, Nov. 2, 2021 /PRNewswire/ — Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized, and targeted induced pluripotent stem cells (iPSC) derived natural killer (NK) and […]

Read More
26 October, 2021

Quantum Surgical Secures 40 Million Euros to Support the Commercial Launch of Epione Its unique Medical Robot

Montpellier, France, October 19th, 2021 – Quantum Surgical, an innovative medical robotic company, announced today that it has secured €40 million (US$48 million) of financing. Led by existing key investor Ally Bridge Group (“ABG”) with an investment of €20 million (US$24 million), this round also includes funding from the European Investment Bank, Bpifrance, and Caisse d’Epargne […]

Read More
8 October, 2021

Morgan Stanley Expansion Capital and Ally Bridge Group Lead $135 Million Investment in Elligo

Proceeds Used to Acquire ClinEdge and Invest Further in Technology & Data Platform September 23, 2021 12:30 PM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Morgan Stanley Expansion Capital and Ally Bridge Group, today announced the firms have completed an investment in Elligo Health Research®, (“Elligo”), a healthcare-enabling research organization powered by the novel IntElligo technology. The $135 […]

Read More
19 August, 2021

Ally Bridge Portfolio News – Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO, Aug. 18, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission’s ongoing regulatory review. Illumina, the global […]

Read More
4 August, 2021

Ally Bridge Portfolio News – Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases

Sonoma Biotherapeutics’ platform and product candidates aim to restore immune system balance through complementary regulatory T cell (Treg) therapy and effector T cell (Teff) conditioning Series B financing comprised of strong syndicate of leading life science investors Financing supports the advancement of Sonoma Bio’s Treg therapy platform, a novel Teff conditioning therapy and the build-out of a […]

Read More
16 July, 2021

Ally Bridge Portfolio News – Rapid Micro Biosystems Announces Pricing of Initial Public Offering

July 14, 2021 21:30 ET | Source: Rapid Micro Biosystems, Inc. LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial […]

Read More
16 July, 2021

Ally Bridge Portfolio News – Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care

Imperative Care to Create Strategic Network of Wholly Owned Development Subsidiaries in Areas of Synergy, Starting with Acquisition of Truvic Medical, Inc., a Peripheral Thrombectomy Innovator July 15, 2021 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners […]

Read More
28 June, 2021

CMR Surgical raises $600 million in Series D financing, led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group

June 28, 2021 07:00 ET | Source: CMR Surgical Funding fully supports the accelerated continued global expansion and commercial scale up of the business Financing round led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group The largest ever MedTech private financing round worldwide to help bring Versius® to hospitals around the worldi CAMBRIDGE, UK – 28 June 2021, 07:01 (BST). CMR Surgical (CMR or “the Company”), a global surgical robotics business, today announces […]

Read More
5 June, 2021

Ally Bridge Portfolio News – GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test

— Galleri’s ability to detect more than 50 types of cancer with a single blood draw could transform early cancer detection as a complement to existing screenings; test now available in U.S. by prescription only — MENLO PARK, Calif., June 4, 2021 — GRAIL, Inc., a healthcare company whose mission is to detect cancer early, […]

Read More